Loading…
Double-hit lymphoma (rearrangements of MYC, BCL-2) during pregnancy: A case report
Double-hit lymphoma is a highly aggressive B-cell lymphoma that is genetically characterized by rearrangements of and and/or . Lymphoma is often accompanied by atypical systemic symptoms similar to physiological changes during pregnancy and is often ignored. Herein, we describe a gravid patient with...
Saved in:
Published in: | World journal of clinical cases 2021-01, Vol.9 (2), p.482-488 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Double-hit lymphoma is a highly aggressive B-cell lymphoma that is genetically characterized by rearrangements of
and
and/or
. Lymphoma is often accompanied by atypical systemic symptoms similar to physiological changes during pregnancy and is often ignored. Herein, we describe a gravid patient with high-grade B-cell lymphoma with a
and
gene rearrangement involving multiple parts of the body.
A 32-year-old female, gestational age 22
wk, complained of abdominal distension, chest tightness and limb weakness lasting approximately 4 wk, and ovarian tumors were found 14 d ago. Auxiliary examinations and a trimanual gynecologic examination suggested malignant ovarian tumor and frozen pelvis. Coupled with rapid progression, severe compression symptoms of hydrothorax, ascites and moderate anemia, labor was induced. Next, biopsy and imaging examinations showed high-grade B-cell lymphoma with a
and
gene rearrangement involving multiple parts of the body. She was referred to the Department of Oncology and Hematology for chemotherapy. Because of multiple recurrences after complete remission, chemotherapy plans were continuously adjusted. At present, the patient remains in treatment and follow-up.
The early detection and accurate diagnosis of lymphoma during pregnancy can help expedite proper multidisciplinary treatment to delay disease progression and decrease the mortality rate. |
---|---|
ISSN: | 2307-8960 2307-8960 |
DOI: | 10.12998/wjcc.v9.i2.482 |